DCGO

+ Watchlist + Portfolio

DocGo Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.42
52-Week Range: $0.40 – $1.73
Market Cap: $42.58M
P/E (TTM): —
EPS (TTM): -1.99
Dividend Yield: —

Advanced Metrics

Price/Book: 0.36
PEG Ratio: —
Return on Equity: -107.79%
Return on Assets: -19.81%
Gross Margin: 30.12%
Operating Margin: -24.41%
Profit Margin: -65.29%
Current Ratio: 1.66
Debt/Equity: 0.27
Total Debt: $25.91M
Free Cash Flow: $5.43M
Revenue Growth: -8.70%
Earnings Growth: —
Enterprise Value: $19.95M

DCGO Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$440.52M	$624.29M	$616.56M	$322.20M
Cost of Revenue	$285.79M	$428.91M	$402.98M	$223.44M
Gross Profit	$154.72M	$195.38M	$213.57M	$98.76M
Research & Development	$5.38M	$10.86M	$11.59M	$13.56M
Selling, General & Admin	$116.94M	$153.04M	$157.41M	$158.69M
Operating Expenses	$132.89M	$180.33M	$184.89M	$187.91M
Operating Income	$21.83M	$15.05M	$28.69M	-$89.16M
EBITDA	$32.40M	$31.49M	$44.57M	-$73.50M
Pretax Income	$22.78M	$16.29M	$27.75M	-$187.50M
Income Tax	-$7.96M	$6.24M	$14.39M	$8.87M
Net Income	$34.58M	$6.86M	$19.99M	-$182.40M
Diluted EPS	0.34	0.06	0.18	-1.84
Diluted Shares	102.98M	105.62M	109.42M	99.07M

DCGO Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$157.34M	$59.29M	$89.24M	$51.02M
Receivables	$103.00M	$262.08M	$210.90M	$92.89M
Current Assets	$271.08M	$338.87M	$304.49M	$152.40M
Total Assets	$393.28M	$490.45M	$455.62M	$217.10M
Current Liabilities	$100.16M	$170.12M	$121.81M	$67.49M
Long-Term Debt	$1.24M	$41.59K	$5.21K	$183.84K
Total Debt	$19.91M	$46.50M	$57.19M	$29.18M
Total Liabilities	$114.35M	$185.28M	$140.44M	$91.23M
Retained Earnings	-$28.97M	-$21.39M	-$1.40M	-$183.80M
Shareholders' Equity	$273.23M	$300.79M	$320.92M	$144.01M
Working Capital	$170.92M	$168.75M	$182.68M	$84.91M

DCGO Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$28.87M	-$64.49M	$70.12M	$34.45M
Capital Expenditure	-$5.50M	-$9.85M	-$5.61M	-$7.43M
Free Cash Flow	$23.37M	-$74.35M	$64.50M	$27.02M
Depreciation & Amortisation	$10.57M	$16.43M	$15.88M	$15.66M
Stock-Based Compensation	$8.05M	$20.97M	$13.63M	$17.44M
Investing Cash Flow	-$38.45M	-$29.61M	-$10.65M	-$39.08M
Financing Cash Flow	-$6.18M	$1.12M	-$24.15M	-$50.82M
Share Repurchases	-$3.73M	$0.00	-$13.76M	-$10.83M
Net Change in Cash	-$15.76M	-$92.98M	$35.31M	-$55.45M

DCGO Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$96.03M	$80.42M	$70.81M	$74.94M	$75.55M
Cost of Revenue	$65.19M	$55.00M	$52.68M	$50.57M	$51.67M
Gross Profit	$30.85M	$25.42M	$18.13M	$24.36M	$23.88M
Research & Development	$3.64M	$2.96M	$3.19M	$3.77M	$3.71M
Selling, General & Admin	$37.44M	$35.96M	$36.20M	$49.09M	$36.24M
Operating Expenses	$44.85M	$42.90M	$43.36M	$56.81M	$42.59M
Operating Income	-$14.00M	-$17.48M	-$25.24M	-$32.44M	-$18.71M
EBITDA	-$10.62M	-$13.49M	-$21.27M	-$28.49M	-$13.93M
Pretax Income	-$14.80M	-$17.92M	-$43.17M	-$111.61M	-$16.68M
Income Tax	-$3.72M	-$4.63M	-$13.51M	$30.73M	$19.28K
Net Income	-$9.41M	-$11.16M	-$27.77M	-$134.07M	-$14.76M
Diluted EPS	-0.09	-0.11	-0.28	-1.37	-0.15
Diluted Shares	101.59M	98.93M	97.81M	97.99M	98.75M

DCGO Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$79.01M	$104.16M	$73.36M	$51.02M	$35.68M
Receivables	$178.76M	$122.76M	$107.02M	$92.89M	$93.97M
Current Assets	$262.53M	$236.57M	$190.23M	$152.40M	$138.17M
Total Assets	$430.79M	$408.26M	$353.78M	$217.10M	$209.23M
Current Liabilities	$107.57M	$100.15M	$73.58M	$67.49M	$77.22M
Long-Term Debt	$2.15K	—	$195.73K	$183.84K	$171.71K
Total Debt	$60.86M	$60.45M	$29.46M	$29.18M	$28.51M
Total Liabilities	$128.87M	$120.53M	$93.12M	$91.23M	$98.02M
Retained Earnings	-$10.81M	-$21.96M	-$49.73M	-$183.80M	-$198.56M
Shareholders' Equity	$309.34M	$297.28M	$270.53M	$144.01M	$132.31M
Working Capital	$154.96M	$136.43M	$116.64M	$84.91M	$60.95M

DCGO Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$9.22M	$34.04M	$1.66M	-$10.47M	-$4.66M
Capital Expenditure	-$1.74M	-$2.01M	-$1.56M	-$2.13M	-$1.10M
Free Cash Flow	$7.47M	$32.04M	$101.16K	-$12.60M	-$5.75M
Depreciation & Amortisation	$3.76M	$3.98M	$3.97M	$3.95M	$2.65M
Stock-Based Compensation	$4.83M	$4.83M	$4.65M	$3.14M	$3.22M
Investing Cash Flow	-$5.29M	-$21.82M	$1.10M	-$13.07M	$1.66M
Financing Cash Flow	-$8.52M	-$7.38M	-$33.05M	-$1.86M	-$2.46M
Share Repurchases	-$5.75M	-$5.08M	$0.00	$0.00	$0.00
Net Change in Cash	-$4.60M	$4.85M	-$30.29M	-$25.40M	-$5.46M

Market Snapshot

About

DocGo Inc. provides mobile health services and medical transportation solutions in the United States and United Kingdom. The company operates a technology-enabled platform that delivers healthcare services directly to patients in their homes, workplaces, and other non-traditional settings. DocGo's services include mobile health clinics, ambulance transportation, and event medical services. The company works with healthcare systems, government agencies, and corporate clients.